Notch3 is important for TGF-β-induced epithelial-mesenchymal transition in non-small cell lung cancer bone metastasis by regulating ZEB-1

Cancer Gene Therapy

Volumn 21, Issue 9, 2014, Pages 364-372

  Liu, L ^a   Chen, X ^b   Wang, Y ^a   Qu, Z ^a   Lu, Q ^a   Zhao, J ^a   Yan, X ^a   Zhang, H ^a   Zhou, Y ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b XI AN CHILDREN S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; INTERLEUKIN 6; NOTCH3 RECEPTOR; PARATHYROID HORMONE RELATED PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR ZEB1; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN; HOMEODOMAIN PROTEIN; NOTCH RECEPTOR; NOTCH3 PROTEIN, HUMAN; PROTEIN BINDING; TRANSCRIPTION FACTOR; ZEB1 PROTEIN, HUMAN;

ARTICLE; BINDING SITE; BONE METASTASIS; CELL INVASION ASSAY; CELL MIGRATION; CLINICAL ARTICLE; EPITHELIAL MESENCHYMAL TRANSITION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IN VITRO STUDY; LUCIFERASE ASSAY; NON SMALL CELL LUNG CANCER; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR INVASION; UPREGULATION; WESTERN BLOTTING; BONE TUMOR; CELL MOTION; DRUG EFFECTS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; LUNG TUMOR; METABOLISM; METASTASIS; PATHOLOGY; REPORTER GENE; SECONDARY; TUMOR CELL LINE;

BINDING SITES; BONE NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HOMEODOMAIN PROTEINS; HUMANS; INTERLEUKIN-6; LUNG NEOPLASMS; NEOPLASM METASTASIS; PARATHYROID HORMONE-RELATED PROTEIN; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RECEPTORS, NOTCH; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 84927088553     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/cgt.2014.39     Document Type: Article

References (39)

1. Leong KG, Niessen K, Kulic I, Raouf A, Eaves C, Pollet I et al. Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Sluginduced repression of E-cadherin. J Exp Med 2007; 204: 2935-2948.
2. Clarhaut J, Gemmill RM, Potiron VA, Ait-Si-Ali S, Imbert J, Drabkin HA et al. ZEB-1, a repressor of the semaphorin 3F tumor suppressor gene in lung cancer cells. Neoplasia 2009; 11: 157-166.
3. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY et al. The epithelialmesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704-715.
4. Vega S, Morales AV, Ocana OH, Valdes F, Fabregat I, Nieto MA. Snail blocks the cell cycle and confers resistance to cell death. Genes Dev 2004; 18: 1131-1143.
5. Smit MA, Geiger TR, Song JY, Gitelman I, Peeper DS. A Twist-Snail axis critical for TrkB-induced epithelial-mesenchymal transition-like transformation, anoikis resistance, and metastasis. Mol Cell Biol 2009; 29: 3722-3737.
6. Sethi S, Macoska J, Chen W, Sarkar FH. Molecular signature of epithelialmesenchymal transition (EMT) in human prostate cancer bone metastasis. Am J Transl Res 2010; 3: 90-99.
7. Evans AJ, Russell RC, Roche O, Burry TN, Fish JE, Chow VW et al. VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail. Mol Cell Biol 2007; 27: 157-169.
8. Yang MH, Wu MZ, Chiou SH, Chen PM, Chang SY, Liu CJ et al. Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol 2008; 10: 295-305.
9. Lois C, Hong EJ, Pease S, Brown EJ, Baltimore D. Germline transmission and tissuespecific expression of transgenes delivered by lentiviral vectors. Science 2002; 295: 868-872.
10. Wang F, Reierstad S, Fishman DA. Matrilysin over-expression in MCF-7 cells enhances cellular invasiveness and pro-gelatinase activation. Cancer Lett 2006; 236: 292-301.
11. Sriuranpong V, Borges MW, Ravi RK, Arnold DR, Nelkin BD, Baylin SB et al. Notch signaling induces cell cycle arrest in small cell lung cancer cells. Cancer Res 2001; 61: 3200-3205.
12. Nicolas M, Wolfer A, Raj K, Kummer JA, Mill P, van Noort M et al. Notch1 functions as a tumor suppressor in mouse skin. Nat Genet 2003; 33: 416-421.
13. Dotto GP. Notch tumor suppressor function. Oncogene 2008; 27: 5115-5123.
14. Dang TP, Gazdar AF, Virmani AK, Sepetavec T, Hande KR, Minna JD et al. Chromosome translocation, overexpression of Notch3, and human lung cancer. J Natl Cancer Inst 2000; 92: 1355-1357.
15. Bedogni B, Warneke JA, Nickoloff BJ, Giaccia AJ, Powell MB. Notch1 is an effector of Akt and hypoxia in melanoma development. J Clin Invest 2008; 118: 3660-3670.
16. Park JT, Li M, Nakayama K, Mao TL, Davidson B, Zhang Z et al. Notch3 gene amplification in ovarian cancer. Cancer Res 2006; 66: 6312-6318.
17. Wang Z, Banerjee S, Li Y, Rahman KM, Zhang Y, Sarkar FH. Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells. Cancer Res 2006; 66: 2778-2784.
18. Miele L, Golde T, Osborne B. Notch signaling in cancer. Curr Mol Med 2006; 6: 905-918.
19. Chen H, Thiagalingam A, Chopra H, Borges MW, Feder JN, Nelkin BD et al. Conservation of the Drosophila lateral inhibition pathway in human lung cancer: a hairy-related protein (HES-1) directly represses achaete-scute homolog-1 expression. Proc Natl Acad Sci USA 1997; 94: 5355-5360.
20. Collins BJ, Kleeberger W, Ball DW. Notch in lung development and lung cancer. Semin Cancer Biol 2004; 14: 357-364.
21. Sethi N, Dai X, Winter CG, Kang Y. Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells. Cancer Cell 2011; 19: 192-205.
22. Powell GJ, Southby J, Danks JA, Stillwell RG, Hayman JA, Henderson MA et al. Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites. Cancer Res 1991; 51: 3059-3061.
23. Tabibzadeh SS, Poubouridis D, May LT, Sehgal PB. Interleukin-6 immunoreactivity in human tumors. Am J Pathol 1989; 135: 427-433.
24. Basolo F, Fiore L, Fontanini G, Conaldi PG, Calvo S, Falcone V et al. Expression of and response to interleukin 6 (IL6) in human mammary tumors. Cancer Res 1996; 56: 3118-3122.
25. Thabard W, Collette M, Mellerin MP, Puthier D, Barille S, Bataille R et al. IL-6 upregulates its own receptor on some human myeloma cell lines. Cytokine 2001; 14: 352-356.
26. Blay JY, Schemann S, Favrot MC. Local production of interleukin 6 by renal adenocarcinoma in vivo. J Natl Cancer Inst 1994; 86: 238.
27. Sahlgren C, Gustafsson MV, Jin S, Poellinger L, Lendahl U. Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc Natl Acad Sci USA 2008; 105: 6392-6397.
28. Vincent T, Neve EP, Johnson JR, Kukalev A, Rojo F, Albanell J et al. A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal transition. Nat Cell Biol 2009; 11: 943-950.
29. Gal A, Sjoblom T, Fedorova L, Imreh S, Beug H, Moustakas A. Sustained TGF beta exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis. Oncogene 2008; 27: 1218-1230.
30. Weinberg RA. Twisted epithelial-mesenchymal transition blocks senescence. Nat Cell Biol 2008; 10: 1021-1023.
31. Thuault S, Tan EJ, Peinado H, Cano A, Heldin CH, Moustakas A. HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition. J Biol Chem 2008; 283: 33437-33446.
32. Aigner K, Dampier B, Descovich L, Mikula M, Sultan A, Schreiber M et al. The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene 2007; 26: 6979-6988.
33. Chua HL, Bhat-Nakshatri P, Clare SE, Morimiya A, Badve S, Nakshatri H. NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2. Oncogene 2007; 26: 711-724.
34. Kopan R, Ilagan MX. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 2009; 137: 216-233.
35. Wang Z, Li Y, Banerjee S, Sarkar FH. Exploitation of the Notch signaling pathway as a novel target for cancer therapy. Anticancer Res 2008; 28: 3621-3630.
36. Li JL, Harris AL. Notch signaling from tumor cells: a new mechanism of angiogenesis. Cancer Cell 2005; 8: 1-3.
37. Dufraine J, Funahashi Y, Kitajewski J. Notch signaling regulates tumor angiogenesis by diverse mechanisms. Oncogene 2008; 27: 5132-5137.
38. Rizzo P, Osipo C, Foreman K, Golde T, Osborne B, Miele L. Rational targeting of Notch signaling in cancer. Oncogene 2008; 27: 5124-5131.
39. Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science 2011; 331: 1559-1564.